- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 303/17 - Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals containing oxirane rings condensed with carbocyclic ring systems having three or more relevant rings
Patent holdings for IPC class C07D 303/17
Total number of patents in this class: 14
10-year publication summary
|
2
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| QBiotics Pty Ltd | 26 |
4 |
| Syngenta Participations AG | 3022 |
1 |
| Sumitomo Chemical Company, Limited | 9004 |
1 |
| ISP Investments Inc. | 465 |
1 |
| JNC Corporation | 1535 |
1 |
| JNC Petrochemical Corporation | 403 |
1 |
| Marshfield Clinic Health System, Inc. | 20 |
1 |
| Symrise AG | 1690 |
1 |
| Washington State University | 474 |
1 |
| Western University of Health Sciences | 48 |
1 |
| Gotion Inc. | 38 |
1 |
| Other owners | 0 |